XML 79 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents for each of these hierarchy levels, the Company's financial assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021 and December 31, 2020:
(In thousands)Level ILevel IILevel IIITotal
At December 31, 2021:
Assets:
Marketable securities$5,771 $— $— $5,771 
Foreign currency derivatives— 196 — 196 
Liabilities:
Foreign currency derivatives— 5,911 — 5,911 
At December 31, 2020:
Assets:
Cash equivalents$107,494 $— $— $107,494 
Marketable securities62,442 — — 62,442 
Foreign currency derivatives— 667 — 667 
Liabilities:
Interest rate swap contracts— 2,403 — 2,403 
Foreign currency derivatives— 3,515 — 3,515 
Schedule of Carrying Values and Fair Values of the Company's Financial Instruments
The carrying values and estimated fair values of the Company's financial instruments, excluding those that are carried at fair value in the consolidated balance sheets are summarized as follows:
(In thousands)December 31, 2021
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term Loan A Facility$664,581 $670,781 
5.00% Notes due April 2024
397,693 403,500 
4.75% Notes due August 2025
792,098 818,000 
4.25% Notes due February 2029
984,098 997,500 
$2,838,470 $2,889,781 

(In thousands)December 31, 2020
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term Loan A facility$669,878 $665,719 
4.75% Notes due December 2022
398,230 400,500 
5.00% Notes due April 2024
991,074 1,015,000 
4.75%Notes due August 2025
790,125 826,160 
$2,849,307 $2,907,379